Skip to main content

CORRECTION article

Front. Microbiol., 12 February 2019
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 10 - 2019 | https://doi.org/10.3389/fmicb.2019.00196
This article is part of the Research Topic Beyond Antimicrobials: Non-Traditional Approaches to Combating Multidrug-Resistant Bacteria View all 24 articles

Corrigendum: A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii

This article is a correction to:

  1. A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii

    1. Read original article
\r\nMinle Wu&#x;Minle Wu1†Kongying Hu&#x;Kongying Hu2†Youhua XieYouhua Xie2Yili LiuYili Liu3Di MuDi Mu4Huimin GuoHuimin Guo2Zhifan ZhangZhifan Zhang4Yingcong ZhangYingcong Zhang1Dong Chang*Dong Chang1*Yi Shi*Yi Shi4*
  • 1Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China
  • 2Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China
  • 3Department of Clinical Laboratory, Shanghai Public Health Clinical Center, Shanghai, China
  • 4Department of Clinical Laboratory, Shanghai Fourth People's Hospital affiliated to Tongji University School of Medicine, Shanghai, China

A Corrigendum on
A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii

by Wu, M., Hu, K., Xie, Y., Liu, Y., Mu, D., Guo, H., et al. (2019). Front. Microbiol. 9:3302. doi: 10.3389/fmicb.2018.03302

There is an error in the Funding statement. The correct name for the Funder is “Shanghai Municipal Commission of Health and Family Planning.”

Additionally, in the published article, there were errors in affiliations 1 and 4. Instead of “Department of Clinical Laboratory, Pudong Hospital Affiliated to Fudan University, Shanghai, China,” it should be “Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China,” and in affiliation 4, instead of “Department of Clinical Laboratory, The Fourth People's Hospital of Shanghai, Shanghai, China,” it should be “Department of Clinical Laboratory, Shanghai Fourth People's Hospital affiliated to Tongji University School of Medicine, Shanghai, China.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: multidrug resistance Acinetobacter baumannii, endolysin, ESKAPE, sepsis, phage therapy, mice model

Citation: Wu M, Hu K, Xie Y, Liu Y, Mu D, Guo H, Zhang Z, Zhang Y, Chang D and Shi Y (2019) Corrigendum: A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii. Front. Microbiol. 10:196. doi: 10.3389/fmicb.2019.00196

Received: 13 January 2019; Accepted: 23 January 2019;
Published: 12 February 2019.

Approved by:

Frontiers in Microbiology Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Wu, Hu, Xie, Liu, Mu, Guo, Zhang, Zhang, Chang and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yi Shi, eWlzaGk3NTBAMTYzLmNvbQ==
Dong Chang, ZG9uZ2NoYW5nMTk2OUAxNjMuY29t

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.